Besim Ogretmen to Leukemia, Myelogenous, Chronic, BCR-ABL Positive
This is a "connection" page, showing publications Besim Ogretmen has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Connection Strength
0.755
-
Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A. Blood. 2011 Jun 02; 117(22):5941-52.
Score: 0.370
-
Alterations of ceramide/sphingosine 1-phosphate rheostat involved in the regulation of resistance to imatinib-induced apoptosis in K562 human chronic myeloid leukemia cells. J Biol Chem. 2007 Apr 13; 282(15):10922-34.
Score: 0.276
-
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells. J Clin Invest. 2013 Oct; 123(10):4144-57.
Score: 0.109